Skip to content
Menu

Sorrento Therapeutics, Inc. SRNE

Full chart Compare
Set alert

Price alert · SRNE

All alert types
0.00 USD 0.00 (-40.00%)

Regular-session close

0.009 Day range 0.01
0.0001 52-week range 0.01
YTD
-88.46%
1 year
-94.55%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

-10.88 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.0×
P/S 0.1×
P/B -0.2×
P/FCF -0.0×
EV/EBITDA -0.2×
EV/Sales 1.8×
FCF Yield -8277.3%

Profitability

Gross Margin 46.8%
Operating Margin -802.6%
Net Margin -911.6%
ROE 3079.0%
ROIC -286.8%
ROA -121.1%

Growth (YoY)

Revenue 18.8%
Operating Income -37.0%
EPS (diluted) 6.2%
Free Cash Flow -5.8%

Financial Health

Current Ratio 0.3×
Quick Ratio 0.3×
Debt / Equity -7.2×
Net Debt / EBITDA -0.2×
Interest Coverage -58.8×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2022-12-31